Tatton-Brown-Rahman overgrowth syndrome: genes and variants

Explore variant evidence for Tatton-Brown-Rahman overgrowth syndrome across 1 analyzed protein (DNMT3A). Linked ClinVar records include 32 pathogenic or likely pathogenic variants, 157 variants of uncertain significance and 19 with conflicting classifications.

Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.

Data updated 2026-11-04. Automated aggregation, not a clinical review date.

Download variant evidence (CSV)

Genes linked to Tatton-Brown-Rahman overgrowth syndrome

Where Tatton-Brown-Rahman overgrowth syndrome variants cluster

ClinVar pathogenic and likely pathogenic variants linked to Tatton-Brown-Rahman overgrowth syndrome

VariantPositionProtein partClinical label
DNMT3A R771Q771SAM-dependent MTase C5-typePathogenic / likely pathogenic (★★)
DNMT3A L508P508ADDPathogenic / likely pathogenic (★★)
DNMT3A R659C659SAM-dependent MTase C5-typePathogenic / likely pathogenic (★★)
DNMT3A Y660H660SAM-dependent MTase C5-typePathogenic / likely pathogenic (★★)
DNMT3A R736H736SAM-dependent MTase C5-typePathogenic / likely pathogenic (★★)
DNMT3A R659H659SAM-dependent MTase C5-typePathogenic / likely pathogenic (★★)
DNMT3A R749C749SAM-dependent MTase C5-typePathogenic / likely pathogenic (★★)
DNMT3A S770L770SAM-dependent MTase C5-typePathogenic / likely pathogenic (★★)
DNMT3A R882C882SAM-dependent MTase C5-typePathogenic / likely pathogenic (★★)
DNMT3A P904L904SAM-dependent MTase C5-typePathogenic / likely pathogenic (★★)
DNMT3A R882H882SAM-dependent MTase C5-typePathogenic / likely pathogenic (★★)
DNMT3A G543R543ADDPathogenic / likely pathogenic (★)
DNMT3A G543S543ADDPathogenic / likely pathogenic (★)
DNMT3A R736L736SAM-dependent MTase C5-typePathogenic / likely pathogenic (★)
DNMT3A R771G771SAM-dependent MTase C5-typePathogenic / likely pathogenic (★)
DNMT3A K299Q299PWWPPathogenic / likely pathogenic (★)
DNMT3A P307L307PWWPPathogenic / likely pathogenic (★)
DNMT3A C586F586ADDPathogenic / likely pathogenic (★)
DNMT3A D702G702SAM-dependent MTase C5-typePathogenic / likely pathogenic (★)
DNMT3A G726V726SAM-dependent MTase C5-typePathogenic / likely pathogenic (★)
DNMT3A T832I832SAM-dependent MTase C5-typePathogenic / likely pathogenic (★)
DNMT3A L373P373Interaction with DNMT1 and DNMT3BPathogenic / likely pathogenic (★)
DNMT3A E545G545ADDPathogenic / likely pathogenic (★)
DNMT3A C557R557ADDPathogenic / likely pathogenic (★)
DNMT3A R729Q729SAM-dependent MTase C5-typePathogenic / likely pathogenic (★)
DNMT3A Q842R842SAM-dependent MTase C5-typePathogenic / likely pathogenic (★)
DNMT3A C494S494ADDPathogenic / likely pathogenic (★)
DNMT3A I310N310PWWPPathogenic / likely pathogenic
DNMT3A M548K548ADDPathogenic / likely pathogenic
DNMT3A L648P648SAM-dependent MTase C5-typePathogenic / likely pathogenic
DNMT3A F902S902SAM-dependent MTase C5-typePathogenic / likely pathogenic
DNMT3A I158N158Pathogenic / likely pathogenic

Uncertain variants prioritized for review in Tatton-Brown-Rahman overgrowth syndrome

VariantPositionProtein partClinical labelEvidence
DNMT3A C586Y586ADDUncertain (★)+7: C586F at the same position is pathogenic; seen in 6.6e-06 of gnomAD DNA copies; REVEL 0.948
DNMT3A R749S749SAM-dependent MTase C5-typeUncertain (★)+7: in a 3D region that tolerates change poorly (1R); R749C at the same position is pathogenic; seen in 2e-06 of gnomAD DNA copies; REVEL 0.883
DNMT3A R882S882SAM-dependent MTase C5-typeConflicting reports (★)+6: 2 other pathogenic changes within 3 positions; R882C at the same position is pathogenic; REVEL 0.884
DNMT3A R736C736SAM-dependent MTase C5-typeConflicting reports (★)+6: 2 other pathogenic changes within 3 positions; R736L at the same position is pathogenic; REVEL 0.923

Which prediction tools work for Tatton-Brown-Rahman overgrowth syndrome

Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.

Same protein, different disease

Diseases related to Tatton-Brown-Rahman overgrowth syndrome

Frequently asked questions

Which genes have records linked to Tatton-Brown-Rahman overgrowth syndrome?

This view contains 1 analyzed proteins: DNMT3A. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.

What do the clinical classifications mean?

Linked records include 32 pathogenic or likely pathogenic variants, 157 variants of uncertain significance and 19 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.

Does the evidence score change a VUS classification?

No. 4 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.

Can I download the variant evidence?

Download the CSV for all 252 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.

About this data

Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.

Download every variant as CSV · Browse all diseases · Methods · About the Center